Literature DB >> 2923569

Massive follicular lymphoid hyperplasia in experimental allergic conjunctivitis. Local antibody production.

M Khatami1, J J Donnelly, J P Haldar, Z G Wei, J H Rockey.   

Abstract

Acute and recurrent allergic conjunctival reactions were induced in guinea pigs by repeated conjunctival applications of fluoresceinyl ovalbumin (FL-OA) for up to 30 months. Early type I conjunctival reactions developed 11 to 25 days after the initial conjunctival exposure to FL-OA. Continuous topical challenges during a six- to 30-month period caused a variety of reactions, including papillary changes and massive hyperplasia of the conjunctival-associated lymphoid tissues. Hyperplasia of lymphoid tissues was induced during a shorter period (two to five months) with a mixture of FL-OA and phorbol ester. Culture fluid from hyperplastic conjunctival lymphoid tissue showed a ratio of IgG1/IgG2 antibody production of up to 15. A low level of recurrence of type I reactivity, after an initial desensitization phenomenon due to a loss of reactive mast cells, correlated with prominent follicular hyperplasia of the conjunctival-associated lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923569     DOI: 10.1001/archopht.1989.01070010443042

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Benign Lymphoid Hyperplasia Presenting as Bilateral Scleral Nodules.

Authors:  Ricardo J Cumba; Rene Vazquez-Botet
Journal:  Case Rep Ophthalmol Med       Date:  2015-09-01

2.  Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?

Authors:  Mahin Khatami
Journal:  Clin Transl Med       Date:  2016-08-23

3.  Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis!

Authors:  Mahin Khatami
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

4.  Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.

Authors:  Hiroshi Maeda; Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-03-01

5.  Cancer; an induced disease of twentieth century! Induction of tolerance, increased entropy and 'Dark Energy': loss of biorhythms (Anabolism v. Catabolism).

Authors:  Mahin Khatami
Journal:  Clin Transl Med       Date:  2018-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.